Kolexia
Chauvet Paul Hématologie
Chauvet Paul
Hématologie
Hôpital Huriez
Lille, France
45 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Myélome multiple Leucémie aigüe myéloïde Lymphomes Maladie du greffon contre l'hôte Leucémie-lymphome lymphoblastique à précurseurs B et T Amyloïdose Syndromes myéloprolifératifs Syndromes myélodysplasiques

Collaborateurs

Voir plus
Srour Micha
Srour Micha
Centre Hospitalier de Lille, Lille, France
Carpentier Benjamin
Carpentier Benjamin
Hôpital Saint Vincent de Paul Lille, Lille, France
Willaume Alexandre
Willaume Alexandre
Hôpital Saint Vincent de Paul Lille, Lille, France
Bossard Jean-Baptiste
Bossard Jean-Baptiste
Centre Hospitalier de Lens, Lens, France

Industries

Voir plus
Janssen
3 collaboration(s)
Dernière en 2023
Chugai
2 collaboration(s)
Dernière en 2023
Novartis
1 collaboration(s)
Dernière en 2022
Takeda Pharmaceutical
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
MYC dependency in GLS1 and NAMPT is a therapeutic vulnerability in multiple myeloma
iScience   04 mars 2024
Philadelphia chromosome-positive B-cell lymphoblastic lymphoma in a child: Case report and literature review.
Pediatric blood & cancer   24 janvier 2024
Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study from the Société Francophone De Greffe De Moelle Et Thérapie Cellulaire (SFGM-TC)
65th ASH Annual Meeting Abstracts   02 novembre 2023
Small myeloid subclones are present at diagnosis of multiple myeloma in patients who develop secondary myelodysplastic syndromes.
Haematologica   19 octobre 2023
Safety and efficacy of nivolumab in patients who failed to achieve a complete remission after CD19-directed CAR T-cell therapy in diffuse large B cell lymphoma.
British journal of haematology   31 mars 2023
The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients.
Blood advances   08 mars 2023
Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC.
Bone marrow transplantation   19 octobre 2022
Successful and safe response to ibrutinib alone in treating relapsed Waldenström macrogobulinemia and related acquired von Willebrand syndrome: an option to consider.
Leukemia & lymphoma   13 septembre 2022
Resurgence of myeloproliferative neoplasm in patients in remission from blast transformation after treatment with hypomethylating agents.
Leukemia research   22 mai 2022
Single-agent 5-azacytidine as post-transplant maintenance in high-risk myeloid malignancies undergoing allogeneic hematopoietic cell transplantation.
Annals of hematology   29 mars 2022